While it is generally accepted that PSA screening has led to a dramatic increase in the prostate cancer detection rate, the debate whether PSA screening significantly reduces mortality from prostate cancer is yet to be resolved [213]. The gene discussed is KLK3; the disease is prostate carcinoma.